Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 67

Sort by

Sort Order Select

Journal Articles

Anticoagulation Challenges in Hematogeriatrics: Effectiveness and Safety of Direct Oral Anticoagulants Vs Vitamin k Antagonist in Elderly with Atrial Fibrillation

Desirée Campoy, MD, Gonzalo Artaza, MD, César A Velasquez, MD, Tania Canals, MD, Erik A Johansson, MD, Katia Flores, MD, Gabriela Bastidas, MD, Silvia Ruiz, MD, Gabriela S Ene, MD PhD, Alessandra Comai, MD, Maricel Subira, MD PhD, Ramón Salinas, MD PhD, Jorge Sierra, MD, Pável E Olivera, MD

Blood (2019) 134 (Supplement_1): 1162.

https://doi.org/10.1182/blood-2019-125150

Published: 2019

Journal Articles

Rivaroxaban Reduces the Levels of Extracellular Vesicles in Patients with Venous Thromboembolism and Non-Valvular Atrial Fibrillation

Sarah Kelliher, MBBS, Luisa Weiss, MSc, Paulina Szklanna, PhD, Karl Egan, PhD, Tadhg Prendiville, MB BCh BAO, Eric Moran, MB BCh BAO, Georgi Petrov, MB BCh BAO, Alfonso Blanco, PhD, Aine Lennon, MSc, Sean Murphy, MD, John Keaney, MD, Fionnuala Ni Ainle, PhD, Patricia Maguire, PhD

Blood (2019) 134 (Supplement_1): 2437.

https://doi.org/10.1182/blood-2019-126166

Published: 2019

Journal Articles

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Jordan K Schaefer, MD, Yun Li, PhD, Xiaowen Kong, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Sahana R Shankar, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc

Blood (2019) 134 (Supplement_1): 787.

https://doi.org/10.1182/blood-2019-122526

Published: 2019

Journal Articles

Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies

Yimin Pearl Wang, BSc, Rohan Kehar, MDMSc,FRCPC, Alla Iansavitchene, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2019) 134 (Supplement_1): 3672.

https://doi.org/10.1182/blood-2019-123870

Published: 2019

Journal Articles

Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation

Pável E Olivera, MD, César A Velasquez, MD, Desirée Campoy, MD, Gonzalo Artaza, MD, Tania Canals, MD, Katia Flores, MD, Silvia Ruiz, MD, Alessandra Comai, MD, Erik A Johansson, MD, Gabriela S Ene, MD PhD, Gabriela Bastidas, MD, Maricel Subira, MD PhD, Jorge Sierra, MD, Ramón Salinas, MD PhD

Blood (2019) 134 (Supplement_1): 3661.

https://doi.org/10.1182/blood-2019-128300

Published: 2019

Journal Articles

Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study

Alfonso J Tafur, MD MS, Na Li, PhD, Nathan Clark, PharmD, Sam Schulman, MD PhD FRCPC, Alex Spyropoulos, MD, Joseph A Caprini, MD MS, FACS, RVT, James Douketis, MD

Blood (2019) 134 (Supplement_1): 710.

https://doi.org/10.1182/blood-2019-125292

Published: 2019

Journal Articles

Efficacy and Safety of Direct Oral Factor Xa Inhibitors in 795 Morbidly Obese Patients

Margarita Kushnir, MD, Yun Choi, MD, Ruth Eisenberg, MS, Devika Rao, MD, Seda Tolu, MD, Jackson Gao, MD, Wenzhu Mowrey, PhD, Henny Heisler Billett, MD

Blood (2018) 132 (Supplement 1): 423.

https://doi.org/10.1182/blood-2018-99-116396

Published: 2018

Journal Articles

Treatment Failure in Patients Receiving Direct Oral Anticoagulants: Clinical Management and Outcomes from a Single-Center Review of 59 Consecutive Patients

Graham McIlroy, MD, Neil Smith, MD FRCPath, Anand Lokare, MD FRCPath, MRCP, Karen Beale, Charalampos Kartsios, MD

Blood (2018) 132 (Supplement 1): 5058.

https://doi.org/10.1182/blood-2018-99-111108

Published: 2018

Journal Articles

Direct Oral Anticoagulants and Mortality in Atrial Fibrillation

Martin Ellis, MD, Sergienko Ruslan, Hammerman Ariel, Sari Greenberg-Dotan, Erez Battat, Orly Hamburger-Avnery, MD, Dan Greenberg, Arbel Ronen

Blood (2018) 132 (Supplement 1): 5061.

https://doi.org/10.1182/blood-2018-99-111182

Published: 2018

Journal Articles

Diffuse Alveolar Hemorrhage Secondary to Direct Oral Anticoagulants: A Systematic Review of Reported Cases

Fawzi Abu Rous, MD, Abdullah al-Abcha, Layan El-khatib, Shiva Shrotriya, MD MPH, Prajwal Dhakal, MBBS

Blood (2018) 132 (Supplement 1): 5069.

https://doi.org/10.1182/blood-2018-99-115545

Published: 2018

Journal Articles

Thrombotic and Bleeding Outcomes Following Perioperative Interruption of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation - a Comparative Analysis

Joseph R. Shaw, MD, Tinghua Zhang, M.Sc., Gregoire Le Gal, MD PhD, James Douketis, MD, Marc Carrier, MD MSc

Blood (2018) 132 (Supplement 1): 1234.

https://doi.org/10.1182/blood-2018-99-111698

Published: 2018

Journal Articles

Comparative Use of Direct Oral Anticoagulants and Warfarin in the Treatment of Atrial Fibrillation and Venous Thromboembolism and Prophylaxis: A Retrospective Single Center Utilization Study

Linda Hoang, MD, Josephine Pineda Dela Cruz, MD, Stephen Farley, PharmD, Julia Sessa, PharmD, Jamie Chin, PharmD, Rose Calixte, PhD, Alexander Hindenburg, MD

Blood (2017) 130 (Supplement 1): 3367.

https://doi.org/10.1182/blood.V130.Suppl_1.3367.3367

Published: 2017

Journal Articles

Apixaban Is Safe and Effective in Morbidly Obese Patients: A Retrospective Analysis of 390 Patients with BMI ≥40

Yun Choi, MD, Margarita Kushnir, MD, Henny Heisler Billett, MD

Blood (2017) 130 (Supplement 1): 1105.

https://doi.org/10.1182/blood.V130.Suppl_1.1105.1105

Published: 2017

Journal Articles

The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation

Xiaoyu Yan, PhD MSc, Gary Peters, MD, Amarnath Sharma, Partha Nandy, Christopher Nessel, MD, Dirk Garmann, Stefan Willmann, Anne Hermanowski-Vosatka, Alexander Solms, Scott D. Berkowitz, MD, Theodore E Spiro, MD, Keith A A Fox, MBBS, Jeffrey I Weitz, MD FRCPC, FACP, Stephan Schmidt, Jonathan P Piccini, Manesh Patel, Richard C Becker, Liping Zhang

Blood (2017) 130 (Supplement 1): 1107.

https://doi.org/10.1182/blood.V130.Suppl_1.1107.1107

Published: 2017

Journal Articles

Safety and Efficacy of Direct-Acting Oral Anticoagulation (DOACs) Based on BMI

Kimberley Doucette, Bhavisha Patel, MD, Anusha Vakiti, Kelly W. Fitzpatrick, MD

Blood (2017) 130 (Supplement 1): 3715.

https://doi.org/10.1182/blood.V130.Suppl_1.3715.3715

Published: 2017

Journal Articles

An Ex Vivo Analysis of Thrombin Generation and Thromboelastometry in Patients Undergoing Treatment with Rivaroxaban Demonstrates Sustained Anticoagulant Effect and High Inter-Individual Variability

Stella Salta, Patrick Van Dreden, PhD, Loula Papageorgiou, Jawed Fareed, PhD, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 3722.

https://doi.org/10.1182/blood.V130.Suppl_1.3722.3722

Published: 2017

Journal Articles

Patient Preferences Regarding Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients — a Discrete Choice Experiment

Sabrina Mueller, Anna-Katharina Meinecke, Sandra Buchwald, Daniel Eriksson, Thomas Wilke

Blood (2017) 130 (Supplement 1): 4727.

https://doi.org/10.1182/blood.V130.Suppl_1.4727.4727

Published: 2017

Journal Articles

Comparative Risk of Acute Kidney Injury with Oral Anticoagulant Use Among Patients with Nonvalvular Atrial Fibrillation

Adi J. Klil-Drori, MD, Laurent Azoulay, PhD, Rui Nie, MSc, Christel Renoux, MD, PhD, Sharon J. Nessim, MD, MSc, Kristian B. Filion, PhD

Blood (2017) 130 (Supplement 1): 700.

https://doi.org/10.1182/blood.V130.Suppl_1.700.700

Published: 2017

Journal Articles

Data of Real-Life Anticoagulant Treatment in Patients Diagnosed with Nonvalvular Atrial Fibrillation and Secondary Prevention of Venous Thromboembolic Disease with Edoxaban: Experience in Our Center

Maria Almudena Garcia Ruiz, Marta Rivas Luque, Pablo Romero Garcia, MDCINE Resident, Manuel Jurado, MD PhD

Blood (2017) 130 (Supplement 1): 4920.

https://doi.org/10.1182/blood.V130.Suppl_1.4920.4920

Published: 2017

Journal Articles

From a DOAC to Warfarin: Reasons Why Patients Switch

Aisling Barrett, MB, BCh, BAO, MRCPI, Sahar Khan, MRCPI, Margaret Moore, RGN, Patricia Ferrins, RGN, BSc, Jeremy Sargent, FRCPath, Patrick Thornton, Philip Murphy, John Quinn

Blood (2017) 130 (Supplement 1): 4910.

https://doi.org/10.1182/blood.V130.Suppl_1.4910.4910

Published: 2017

NARROW

Anticoagulation Challenges in Hematogeriatrics: Effectiveness and Safety of Direct Oral Anticoagulants Vs Vitamin k Antagonist in Elderly with Atrial Fibrillation

Rivaroxaban Reduces the Levels of Extracellular Vesicles in Patients with Venous Thromboembolism and Non-Valvular Atrial Fibrillation

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies

Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation

Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study

Efficacy and Safety of Direct Oral Factor Xa Inhibitors in 795 Morbidly Obese Patients

Treatment Failure in Patients Receiving Direct Oral Anticoagulants: Clinical Management and Outcomes from a Single-Center Review of 59 Consecutive Patients

Direct Oral Anticoagulants and Mortality in Atrial Fibrillation

Diffuse Alveolar Hemorrhage Secondary to Direct Oral Anticoagulants: A Systematic Review of Reported Cases

Thrombotic and Bleeding Outcomes Following Perioperative Interruption of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation - a Comparative Analysis

Comparative Use of Direct Oral Anticoagulants and Warfarin in the Treatment of Atrial Fibrillation and Venous Thromboembolism and Prophylaxis: A Retrospective Single Center Utilization Study

Apixaban Is Safe and Effective in Morbidly Obese Patients: A Retrospective Analysis of 390 Patients with BMI ≥40

The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation

Safety and Efficacy of Direct-Acting Oral Anticoagulation (DOACs) Based on BMI

An Ex Vivo Analysis of Thrombin Generation and Thromboelastometry in Patients Undergoing Treatment with Rivaroxaban Demonstrates Sustained Anticoagulant Effect and High Inter-Individual Variability

Patient Preferences Regarding Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients — a Discrete Choice Experiment

Comparative Risk of Acute Kidney Injury with Oral Anticoagulant Use Among Patients with Nonvalvular Atrial Fibrillation

Data of Real-Life Anticoagulant Treatment in Patients Diagnosed with Nonvalvular Atrial Fibrillation and Secondary Prevention of Venous Thromboembolic Disease with Edoxaban: Experience in Our Center

From a DOAC to Warfarin: Reasons Why Patients Switch

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only